The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies

Abstract Background The association between immune-related adverse events (irAEs) and survival outcomes in patients with advanced melanoma receiving therapy with immune checkpoint inhibitors (ICIs) has not been well established, particularly in Asian melanoma. Methods We retrospectively reviewed 49...

Full description

Bibliographic Details
Main Authors: Chiao-En Wu, Chan-Keng Yang, Meng-Ting Peng, Pei-Wei Huang, Ching-Fu Chang, Kun-Yun Yeh, Chun-Bing Chen, Chih-Liang Wang, Chao-Wei Hsu, I-Wen Chen, Cheng-Tao Lin, Shir-Hwa Ueng, Gigin Lin, Yu-Fen Lin, Chi-Yuan Cheng, John Wen-Cheng Chang
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Cancer
Subjects:
Immune checkpoint inhibitors
irAE
Skin toxicity
Vitiligo
Endocrine
Melanoma
Online Access:http://link.springer.com/article/10.1186/s12885-020-07508-7

Internet

http://link.springer.com/article/10.1186/s12885-020-07508-7

Similar Items